Research graph
References from The therapeutic prescription for the organ transplant recipient: the linkage of immunosuppression and antimicrobial strategies. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1007/978-1-4615-2490-8_24
10.1007/978-1-4615-2490-8_24 · External reference
10.1056/nejm199806113382407
10.1056/nejm199806113382407 · External reference
Unresolved reference
1996 · External reference
Recent insights into the mechanisms of anti‐inflammatory steroid action
1992 · External reference
10.1006/cimm.1993.1134
10.1006/cimm.1993.1134 · External reference
10.7326/0003-4819-119-12-199312150-00007
10.7326/0003-4819-119-12-199312150-00007 · External reference
Unresolved reference
1996 · External reference
Unresolved reference
1996 · External reference
The George Hitchings and Gertrude Elion Lecture: The pharmacology of azathioprine
10.1111/j.1749-6632.1993.tb35897.x · 1993 · External reference
Immunosuppression in renal transplantation. I. cyclosporine and azathioprine
10.1111/j.1399-0012.1991.tb00137.x · 1991 · External reference
10.1515/dmdi.1997.14.1.17
10.1515/dmdi.1997.14.1.17 · External reference
10.1007/978-1-4615-5381-6_96
10.1007/978-1-4615-5381-6_96 · External reference
10.1146/annurev.iy.10.040192.002511
10.1146/annurev.iy.10.040192.002511 · External reference
10.1126/science.1702904
10.1126/science.1702904 · External reference
NF‐Atp, a T lymphocyte DNA‐binding protein that is a target for calcineurin and immunosuppressive drugs
10.1016/s0021-9258(18)53757-1 · 1993 · External reference
10.1111/j.1749-6632.1993.tb17137.x
10.1111/j.1749-6632.1993.tb17137.x · External reference
10.1097/00007890-199107000-00025
10.1097/00007890-199107000-00025 · External reference
10.1016/0092-8674(95)90439-5
10.1016/0092-8674(95)90439-5 · External reference
10.1016/0092-8674(91)90124-h
10.1016/0092-8674(91)90124-h · External reference
10.1016/s0021-9258(18)47212-2
10.1016/s0021-9258(18)47212-2 · External reference
10.1038/383837a0
10.1038/383837a0 · External reference
10.1111/j.1749-6632.1993.tb17138.x
10.1111/j.1749-6632.1993.tb17138.x · External reference
The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes
10.4049/jimmunol.143.2.718 · 1989 · External reference
Effect of FK‐506 on human mixed lymphocyte reaction in vitro
1987 · External reference
FK 506 and cyclosporine inhibit antigen‐ or mitogen‐induced monokine and lymphokine production in vitro
1992 · External reference
10.1097/00007890-198902000-00034
10.1097/00007890-198902000-00034 · External reference
10.1097/00007890-199212000-00016
10.1097/00007890-199212000-00016 · External reference
10.1016/0165-2478(91)90101-f
10.1016/0165-2478(91)90101-f · External reference
10.1111/j.1348-0421.1992.tb02090.x
10.1111/j.1348-0421.1992.tb02090.x · External reference
10.1073/pnas.92.11.4947
10.1073/pnas.92.11.4947 · External reference
10.1161/01.res.76.3.412
10.1161/01.res.76.3.412 · External reference
10.1091/mbc.3.9.981
10.1091/mbc.3.9.981 · External reference
10.1016/0378-1119(93)90264-4
10.1016/0378-1119(93)90264-4 · External reference
10.1074/jbc.270.36.20875
10.1074/jbc.270.36.20875 · External reference
10.1074/jbc.270.2.815
10.1074/jbc.270.2.815 · External reference
p70 S6 kinase sensitivity to rapamycin is eliminated by amino acid substitution of Thr229
10.4049/jimmunol.157.2.656 · 1996 · External reference
In vivo use of rapamycin suppresses neither IL‐2 production nor IL‐2 receptor expression in rat transplant model
1993 · External reference
Cytokine and alloantibody networks in long‐term cardiac allografts in rapamycin‐treated sensitized rat recipients
1995 · External reference
Inhibition of T and B lymphocyte proliferation by rapamycin
1991 · External reference
10.1016/s0171-2985(11)80238-x
10.1016/s0171-2985(11)80238-x · External reference
10.3109/08923979309035233
10.3109/08923979309035233 · External reference
10.1097/00007890-199502150-00014
10.1097/00007890-199502150-00014 · External reference
10.1002/hep.1840150520
10.1002/hep.1840150520 · External reference
10.1097/00007890-199306000-00037
10.1097/00007890-199306000-00037 · External reference
10.1172/jci119038
10.1172/jci119038 · External reference
10.1097/00007691-199512000-00023
10.1097/00007691-199512000-00023 · External reference
Inhibition of human B cell responses in vitro by RS‐61443, cyclosporine A and DAB486 IL‐2
1991 · External reference
10.1097/00007890-199102000-00053
10.1097/00007890-199102000-00053 · External reference
Effects of the inhibitors of IMP dehydrogenase, tiazofurin and mycophenolic acid, on glycoprotein metabolism
1985 · External reference
Inhibition of mannosylation on human monocyte surface glycoprotein could explain some of the anti‐inflammatory effects of mycophenolate mofetil
1994 · External reference
10.1056/nejm198108063050603
10.1056/nejm198108063050603 · External reference
10.1056/nejm198508083130601
10.1056/nejm198508083130601 · External reference
Unresolved reference
External reference
10.1128/aac.37.4.619
10.1128/aac.37.4.619 · External reference
10.1097/00007890-199201000-00013
10.1097/00007890-199201000-00013 · External reference
10.7326/0003-4819-123-1-199507010-00002
10.7326/0003-4819-123-1-199507010-00002 · External reference
Effect of oral acyclovir or ganciclovir after preemptive intravenous ganciclovir therapy to prevent CMV disease in CMV seropositive renal and liver transplant patients receiving antilymphocyte antibody therapy
External reference
10.1097/00007890-199803150-00026
10.1097/00007890-199803150-00026 · External reference
Cytomegalovirus infection in transplant recipients. The role of tumor necrosis factor
10.1097/00007890-199409000-00007 · 1994 · External reference
Prevention and treatment of cytomegalovirus disease in heart transplant patients
External reference
Unresolved reference
1995 · External reference
